Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
REPATHA (Evolocumab) is a human monoclonal immunoglobulin G2 (IgG2) directed against human proprotein convertase subtilisin kexin 9 (PCSK9). Evolocumab has an approximate molecular weight (MW) of 144 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Evolocumab is supplied at a concentration of 140 mg/mL as a sterile, preservative-free, clear to opalescent, colorless to pale yellow solution, which contains 1.2 mg/mL acetate, 0.1 mg/mL polysorbate 80, 25 mg/mL proline, and Water for Injection.
Properties
Name | Evolocumab |
CAS NO. | 1256937-27-5 |
Type | Whole antibody |
Source | Human |
Target | PCSK9 |
Clone | Monoclone |
Molecular Weight | 144 kDa |
Formula | C6242H9648N1668O1996S56 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China (Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Evolocumab
